These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9635018)

  • 1. Effect of taurine on biliary metabolites of glutathione in liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Adv Exp Med Biol; 1998; 442():85-9. PubMed ID: 9635018
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver.
    Yan CC; Huxtable RJ
    Life Sci; 1995; 57(6):617-26. PubMed ID: 7623629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the pyrrolizidine alkaloid monocrotaline on taurine and sulfur amino acid metabolism in the rat liver.
    Yan CC; Huxtable RJ
    Adv Exp Med Biol; 1996; 403():135-45. PubMed ID: 8915351
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyrrolizidine alkaloid-induced depletion of taurine from rat liver in vivo and in vitro.
    Sun Y; Hasal SJ; Yan CC; Brendel K; Huxtable RJ
    Adv Exp Med Biol; 1998; 442():71-7. PubMed ID: 9635016
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver.
    Nigra L; Huxtable RJ
    Toxicon; 1992 Oct; 30(10):1195-202. PubMed ID: 1440625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of taurine on toxicity of the pyrrolizidine alkaloid monocrotaline in rats.
    Yan CC; Huxtable RJ
    Adv Exp Med Biol; 1996; 403():315-25. PubMed ID: 8915367
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of taurine in precision-cut liver slices exposed to the pyrrolizidine alkaloid retrorsine.
    Hasal SJ; Sun Y; Yan CC; Brendel K; Huxtable RJ
    Adv Exp Med Biol; 1998; 442():79-83. PubMed ID: 9635017
    [No Abstract]   [Full Text] [Related]  

  • 10. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of taurine and guanidinoethane sulfonate on toxicity of the pyrrolizidine alkaloid monocrotaline.
    Yan CC; Huxtable RJ
    Biochem Pharmacol; 1996 Feb; 51(3):321-9. PubMed ID: 8573199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat.
    Yan CC; Huxtable RJ
    Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal variation in biliary excretion of glutathione and related sulfur-containing compounds in rats.
    Yan CC; Huxtable RJ
    Proc West Pharmacol Soc; 1997; 40():61-3. PubMed ID: 9436214
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Huxtable RJ; Bowers R; Mattocks AR; Michnicka M
    Adv Exp Med Biol; 1991; 283():605-12. PubMed ID: 1906228
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of an alkylating metabolite, dehydromonocrotaline, from the isolated liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Proc West Pharmacol Soc; 1994; 37():107-8. PubMed ID: 7984635
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
    Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
    Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monocrotaline, a pyrrolizidine alkaloid, on glutathione metabolism in the rat.
    Yan CC; Huxtable RJ
    Biochem Pharmacol; 1996 Feb; 51(3):375-9. PubMed ID: 8573205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.